Live from the NIH registry
Studies recruiting near Akron right now
Top 25 of 393 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University Hospitals Sharon Health Center — Wadsworth, Ohio (11.5 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
UH Seidman Cancer Center at Southwest General Hospital — Middleburg Heights, Ohio (24.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
Gabrail Cancer Center Research — Canton, Ohio (20.8 mi)
· Sponsor: OncoNano Medicine, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (0.2 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Canton, Ohio (20.8 mi)
· Sponsor: AstraZeneca
Investigations of Reproductive Cancers in Women
Uterine Cancer
N/A
Observational 4,500 participants sought
Summa Health — Akron, Ohio (0.2 mi)
· Sponsor: PinkDx, Inc.
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (0.2 mi)
· Sponsor: Anagram Therapeutics, Inc.
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Yanke Bionics - W Exchange St — Akron, Ohio (0.2 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
University Hospitals Parma Medical Center — Parma, Ohio (24.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
Gabrail Cancer Center — Canton, Ohio (20.8 mi)
· Sponsor: Context Therapeutics Inc.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Aultman Hospital — Canton, Ohio (20.8 mi)
· Sponsor: Duke University
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Nonmuscle-invasive Bladder Cancer
Phase 2
Interventional 160 participants sought
Helios Clinical Research — Middleburg Heights, Ohio (24.6 mi)
· Sponsor: ImmVira Pharma Co. Ltd
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
UH Minoff Health Center at Chagrin Highlands — Orange, Ohio (25.7 mi)
· Sponsor: Pfizer
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Retina Associates Of Cleveland - Beachwood /ID# 275985 — Beachwood, Ohio (26.6 mi)
· Sponsor: AbbVie
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Focal Segmental Glomerulosclerosis
N/A
Interventional 35 participants sought
Akron Children's Hospital — Akron, Ohio (0.2 mi)
· Sponsor: Kaneka Medical America LLC
International Rare Brain Tumor Registry
Astroblastoma, BCOR ITD Sarcoma
N/A
Observational 5,800 participants sought
Akron Children's Hospital — Akron, Ohio (0.2 mi)
· Sponsor: Children's National Research Institute
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Cancer, Melanoma Stage III
Phase 1, Phase 2
Interventional 240 participants sought
Gabrail Cancer Center Research — Canton, Ohio (20.8 mi)
· Sponsor: Krystal Biotech, Inc.
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Polymyositis, Dermatomyositis
Phase 3
Interventional 240 participants sought
Research Site — Middleburg Heights, Ohio (24.6 mi)
· Sponsor: AstraZeneca
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Cognitive Impairment Associated With Schizophrenia (CIAS)
Phase 2
Interventional 150 participants sought
Neuro-Behavioral Clinical Research — North Canton, Ohio (15.4 mi)
· Sponsor: Kynexis B.V.
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Metastatic Pancreatic Adenocarcinoma
Phase 3
Interventional 480 participants sought
Gabrail Cancer Center Research — Canton, Ohio (20.8 mi)
· Sponsor: Eleison Pharmaceuticals LLC.
The PREDICT Registry:
DCIS, Stage 0 Breast Cancer
N/A
Observational 3,000 participants sought
Cleveland Clinic Akron General — Akron, Ohio (0.2 mi)
· Sponsor: PreludeDx
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Cleveland Clinic Akron General — Akron, Ohio (0.2 mi)
· Sponsor: NRG Oncology
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES)
Phase 3
Interventional 14 participants sought
Research Site — Highland Hills, Ohio (25.5 mi)
· Sponsor: AstraZeneca
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Psoriatic Arthritis
Phase 3
Interventional 1,182 participants sought
Paramount Medical Research & Consulting, LLC — Middleburg Heights, Ohio (24.6 mi)
· Sponsor: Takeda
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
Akron Children's Hospital — Akron, Ohio (0.2 mi)
· Sponsor: Children's Hospital of Philadelphia